GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NSPR · Jun 30, 2025

InspireMD, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001641172-25-022040General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

32.40% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-468.67% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

2.24% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

171.77% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

17.60% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-732.23% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

215.64% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

180.60% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building

Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20267/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 23.48%
Current: 32.40%
Delta: 8.92%

Cash Generation Increased

Previous: -575.02%
Current: -468.67%
Delta: 106.34%

Growth Increased

Previous: 1.19%
Current: 2.24%
Delta: 1.05%

Inventory Pressure Decreased

Previous: 184.56%
Current: 171.77%
Delta: -12.80%

Margin Decreased

Previous: 19.10%
Current: 17.60%
Delta: -1.49%

Profitability Increased

Previous: -749.51%
Current: -732.23%
Delta: 17.28%

R And D Intensity Decreased

Previous: 265.47%
Current: 215.64%
Delta: -49.83%

Sbc Intensity Increased

Previous: 178.48%
Current: 180.60%
Delta: 2.11%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · NSPR Fundamental State →Has State · InspireMD, Inc. →Transitioned To · NSPR Fundamental State →Transitioned To · NSPR CAPEX_INTENSITY_INCREASED →Transitioned To · NSPR CASH_GENERATION_INCREASED →Transitioned To · NSPR GROWTH_INCREASED →Transitioned To · NSPR PROFITABILITY_INCREASED →Transitioned To · NSPR R_AND_D_INTENSITY_DECREASED →Transitioned To · NSPR SBC_INTENSITY_INCREASED →Transitioned To · NSPR INVENTORY_PRESSURE_DECREASED →Transitioned To · NSPR MARGIN_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.